Why Are AngioDynamics Shares Trading Lower Today
Portfolio Pulse from Vandana Singh
AngioDynamics Inc reported Q4 FY23 adjusted EPS of $0.02, in line with consensus and higher than $0.01 a year ago. Q4 sales increased 4.7% Y/Y to $91.07 million, beating the analyst consensus of $90.3 million. However, the company reported a Q4 loss of $21.46 million, much wider than $6.27 million reported a year ago. The company's shares are down 2.52% in premarket trading.
July 12, 2023 | 12:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AngioDynamics reported Q4 FY23 adjusted EPS of $0.02, in line with consensus and higher than $0.01 a year ago. Q4 sales increased 4.7% Y/Y to $91.07 million, beating the analyst consensus of $90.3 million. However, the company reported a Q4 loss of $21.46 million, much wider than $6.27 million reported a year ago. The company's shares are down 2.52% in premarket trading.
Despite reporting Q4 sales that beat analyst consensus and an adjusted EPS in line with consensus, AngioDynamics reported a much wider Q4 loss than a year ago. This negative news is likely to have a short-term negative impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100